Company news
Shenzhen Chipscreen Biosciences Co. Ltd. news in 2026
Shenzhen Chipscreen Biosciences Co. Ltd.'s news releases, calls and decks from 2026, newest first.
Announcement on the Thawing of Partially Frozen Shares Held by a Shareholder Owning 5% or More of the Company’s Equity
January 30, 2026
Announcement on Proposed Participation of Connected Persons in the Subscription of Shares Issued to Specific Objects and Related Party Transaction
January 29, 2026
Announcement on Earnings Preannouncement for 2025
January 26, 2026
Indicative Announcement on "Chipscreen Convertible Bonds" Expected to Meet Conditions for Redemption
January 22, 2026
Announcement on Estimated Amount of Daily Related Party Transactions in 2026
January 15, 2026
Prospectus for Issuance of A-shares to Specific Objects in 2024 (Registration Draft)
January 14, 2026
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of Chiauranib Capsules
January 8, 2026
Announcement on Voluntary Disclosure of Approval of Chidamide for Market Release by the Pharmaceutical Administration Bureau, Macao SAR
January 7, 2026
Announcement on Voluntary Disclosure of Acceptance of the Clinical Trial Application for Chiglitazar Sodium Sustained-release Tablets
January 5, 2026
Announcement on Voluntary Disclosure on the Acceptance of the Clinical Trial Application for CS08399 Tablets
December 31, 2025